By Heredia, Costa Rica — Roche, a leading global pharmaceutical and diagnostics company, has officially opened its new campus in Costa Rica, signifying a substantial investment in the country’s future and its strategic importance in Roche’s global operations. This state-of-the-art facility reflects Roche’s confidence in Costa Rica’s potential and its dedication to driving excellence in healthcare.
The Roche Costa Rica Campus, located in the San José province, is designed to be a cutting-edge research and development hub.
It boasts advanced laboratories, collaborative workspaces, and innovative technology aimed at fostering groundbreaking medical research and development. This facility is set to play a crucial role in Roche’s global strategy, particularly in biotechnology, diagnostics, and personalized medicine.
The inauguration of our Costa Rica Campus is a testament to our long-term commitment to the region. We believe in the potential of Costa Rica to be a leader in healthcare innovation, and this campus will be at the forefront of that journey
María Angélica Lara, General Manager of Roche Costa Rica
The campus is expected to create hundreds of high-quality jobs, providing significant opportunities for local talent and contributing to the economic growth of Costa Rica. Roche’s investment in this facility is not just a financial one; it is also an investment in the people and future of Costa Rica. The company’s focus on sustainability is evident in the campus’s design, which includes energy-efficient systems, green spaces, and initiatives aimed at reducing waste, all aligning with Costa Rica’s environmental goals.
Roche’s decision to establish a major hub in Costa Rica underscores the company’s belief in the country’s strategic advantages. These include a skilled workforce, a stable political environment, and robust infrastructure.
The Costa Rica Campus will serve as a central node for Roche’s regional and global operations, enhancing its ability to deliver high-quality healthcare solutions worldwide.
This move is part of Roche’s broader strategy to expand its footprint in key regions, allowing it to better serve patients and healthcare systems around the world. The Costa Rica Campus is expected to facilitate collaboration with local and international partners, drive innovation, and accelerate the development of new medical solutions.
Looking ahead, the Roche Costa Rica Campus is set to become a center of excellence in the region, contributing significantly to the advancement of medical science and improving patient outcomes. The company’s ongoing investments in technology, research, and human resources reflect its commitment to maintaining a leadership position in the global healthcare industry.
Congratulations to Roche on the opening of this new center that consolidates its administrative operations in the country. The Roche Costa Rica Campus is a testament to the company’s confidence in the country, our investment climate, and the specialized human talent we offer. From PROCOMER, we reiterate our commitment to Roche in each and every process of establishment and post-establishment, as well as in promoting the country’s competitiveness, so that its operations develop successfully
Laura López, General Manager of PROCOMER
The inauguration of the Roche Costa Rica Campus marks a significant step forward for both the company and the country.
It highlights Roche’s dedication to innovation, sustainability, and excellence, while also reinforcing Costa Rica’s growing reputation as a hub for scientific and technological advancement.
This strategic investment is poised to drive economic growth, create job opportunities, and contribute to the development of groundbreaking healthcare solutions.
For further information, visit roche.com
About Roche:
Roche is a global pioneer in pharmaceuticals and diagnostics, dedicated to advancing science to improve people’s lives. The company offers innovative solutions in various therapeutic areas, including oncology, immunology, infectious diseases, ophthalmology, and diseases of the central nervous system. Roche’s commitment to sustainability and responsible business practices is integral to its operations worldwide.
